Connect with us
[ad_1] Newswise — BALTIMORE, April 6, 2023 – After helping to develop and test new mRNA technologies for COVID-19 vaccines, University of Maryland School of Medicine...
[ad_1] Newswise — TAMPA (Sunday, March 26, 2023) – After resolving missing data burdens, the ENGOT-OV16/NOVA (NCT01847274) study data shows no difference in overall survival for...
[ad_1] Newswise — TAMPA (Saturday, March 25, 2023) – Administering PARP inhibitor (PARPi) olaparib prior to surgical intervention and chemotherapy in ovarian cancer patients with a...
[ad_1] Newswise — Nonalcoholic steatohepatitis (NASH)-related cirrhosis can lead to serious liver-related outcomes. In a phase 2 trial, lead author Rohit Loomba, MD, University of California San...
[ad_1] Newswise — The constant evolution of new COVID-19 variants makes it critical for clinicians to have multiple therapies in their arsenal for treating drug-resistant infections....
[ad_1] WeightWatchers, the 60-year-old diet firm, announced this week it would acquire a telehealth company whose providers prescribe anti-obesity drugs for growing numbers of eager online...
[ad_1] Newswise — COLUMBUS, Ohio – Despite racial and ethnic minority groups making up nearly half of the United States population, underrepresentation in clinical trials remains...
[ad_1] Newswise — Ulcerative colitis assessment could be improved after new research shows that an artificial intelligence model could predict flare-ups and complications after reading biopsies....
[ad_1] Newswise — New York, NY (February 17, 2023)—Immunotherapy after surgery increased bladder cancer patients’ chance of staying cancer-free compared to patients who received a placebo,...
[ad_1] Newswise — The hormone kisspeptin could be used to treat women and men distressed by their low sexual desire, according to two new studies. The...
[ad_1] Newswise — Patients with myelofibrosis had clinically significant improvement in disease-related symptoms, including anemia and spleen enlargement, when treated with the targeted therapy momelotinib, according...
[ad_1] For all the legwork that public-health experts have done over the past few years to quash comparisons between COVID-19 and the flu, there sure seems...
[ad_1] Newswise — X-linked adrenoleukodystrophy (X-ALD) is the most common of a group of around 50 rare diseases of the white matter of the brain, the so-called...
[ad_1] Three years into the global fight against SARS-CoV-2, the arsenal to combat long COVID remains depressingly bare. Being vaccinated seems to reduce people’s chances of...
[ad_1] FINDINGS New UCLA-led research suggests that antiretroviral drugs called TAF and TDF directly reduce energy production by mitochondria, structures inside cells that generate the power...
[ad_1] By Foster Lasley, MD, as told to Kara Mayer Robinson If your lung cancer can’t be treated with surgery, it doesn’t mean there’s nothing...
[ad_1] Newswise — Pain in the back or the neck is extremely common and accounts for more healthcare spending than any other health condition. A study...
[ad_1] Newswise — In a study examining the link between non-alcoholic fatty liver disease (NAFLD) and brain dysfunction, scientists at the Roger Williams Institute of Hepatology,...
[ad_1] Newswise — Eosinophilic esophagitis (EoE) is an allergic condition of the esophagus that is on the rise throughout the United States. Patients with the condition...
[ad_1] Newswise — In the Phase I/II CodeBreaK 100 trial, the KRAS G12C inhibitor sotorasib achieved meaningful anticancer activity with an acceptable safety profile in heavily...